Triglyceride increase can predict lipodystrophy in HIV patients under highly active antiretroviral therapy [5]

AIDS

Volumn 16, Issue 10, 2002, Pages 1434-1436

  Rodriguez Guardado, Azucena ^a   Maradona, Jose Antonio ^a   Carton, Jose Antonio ^a   Asensi, Victor ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT; CHOLESTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ADULT; CHOLESTEROL BLOOD LEVEL; DIAGNOSTIC TEST; DRUG EFFECT; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LIPODYSTROPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; MIDDLE AGED;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOLOGICAL MARKERS; CHOLESTEROL; COMPARATIVE STUDY; FEMALE; HIV INFECTIONS; HUMAN; LIPODYSTROPHY; MALE; MIDDLE AGE; TRIGLYCERIDES; HUMANS; MIDDLE AGED;

EID: 0037024772     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200207050-00022     Document Type: Letter

References (6)

1. Lipodystrophy, metabolic disorders and human immunodeficiency virus infection: Aquitaine Cohort, France 1999
2. Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment database
3. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: A cohort study
4. Description of lipodystrophy in the HIV Outpatient Study (HOPS)
5. Risk of lipodystrophy in HIV-1 infected patients treated with protease inhibitors: A prospective cohort study
6. Lipodystrophic syndromes in a French cohort of HIV-infected patients receiving HAART with protease inihibitor